Skip to main content

Animations

MJFF Publications

241 - 250 of 6560 Results
Title
Year
  • Year
  • 2022
  • 2019
  • 2026
  • 2018
  • 2024
  • 2025
  • 2023
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13414
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain Development
    Journal Name: Developmental Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/dneu.22684
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Revealing and Exploiting the Biochemistry of O -GlcNAc through Protein Semisynthesis
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.biochem.6c00095
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022
    Citation Count: 31
  • Summary Details
    OPEN
    Title: An augmented reality dual-task intervention improves postural stability in individuals with Parkinson’s disease
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2024.11.007
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Substrate recognition by the human mitochondrial processing peptidase and its processing of PINK1
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2025.110860
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trial
    Journal Name: Stem Cell Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13287-025-04577-y
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.